STAAR Surgical Research and Development Expenses 2010-2024 | STAA
STAAR Surgical research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
STAAR Surgical Annual Research and Development Expenses (Millions of US $) |
2023 |
$44 |
2022 |
$36 |
2021 |
$34 |
2020 |
$32 |
2019 |
$25 |
2018 |
$22 |
2017 |
$20 |
2016 |
$21 |
2015 |
$15 |
2014 |
$12 |
2013 |
$7 |
2012 |
$6 |
2011 |
$6 |
2010 |
$6 |
2009 |
$6 |
STAAR Surgical Quarterly Research and Development Expenses (Millions of US $) |
2024-09-30 |
$14 |
2024-06-30 |
$14 |
2024-03-31 |
$13 |
2023-12-31 |
$11 |
2023-09-30 |
$11 |
2023-06-30 |
$12 |
2023-03-31 |
$10 |
2022-12-31 |
$10 |
2022-09-30 |
$10 |
2022-06-30 |
$9 |
2022-03-31 |
$8 |
2021-12-31 |
$9 |
2021-09-30 |
$8 |
2021-06-30 |
$8 |
2021-03-31 |
$8 |
2020-12-31 |
$9 |
2020-09-30 |
$9 |
2020-06-30 |
$7 |
2020-03-31 |
$7 |
2019-12-31 |
$7 |
2019-09-30 |
$6 |
2019-06-30 |
$6 |
2019-03-31 |
$6 |
2018-12-31 |
$6 |
2018-09-30 |
$6 |
2018-06-30 |
$5 |
2018-03-31 |
$5 |
2017-12-31 |
$6 |
2017-09-30 |
$5 |
2017-06-30 |
$5 |
2017-03-31 |
$5 |
2016-12-31 |
$5 |
2016-09-30 |
$4 |
2016-06-30 |
$5 |
2016-03-31 |
$7 |
2015-12-31 |
$4 |
2015-09-30 |
$4 |
2015-06-30 |
$4 |
2015-03-31 |
$4 |
2014-12-31 |
$3 |
2014-09-30 |
$3 |
2014-06-30 |
$2 |
2014-03-31 |
$3 |
2013-12-31 |
$2 |
2013-09-30 |
$2 |
2013-06-30 |
$2 |
2013-03-31 |
$1 |
2012-12-31 |
$2 |
2012-09-30 |
$2 |
2012-06-30 |
$2 |
2012-03-31 |
$2 |
2011-12-31 |
$2 |
2011-09-30 |
$1 |
2011-06-30 |
$1 |
2011-03-31 |
$1 |
2010-12-31 |
$2 |
2010-09-30 |
$1 |
2010-06-30 |
$1 |
2010-03-31 |
$2 |
2009-12-31 |
$1 |
2009-09-30 |
$2 |
2009-06-30 |
$1 |
2009-03-31 |
$1 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$1.288B |
$0.322B |
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|